That's important, since the way a protein in the body folds determines if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we have to know how these proteins fold if we desire a drug to work. Historically, this has actually been a trial-and-error process (jeff brown biotech genome sequencing). And now, Alpha, Fold can forecast protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're created to do. This was a breakthrough nearly no one noticed. However it's going to have profound implications for treating disease. I forecast that Alpha, Fold will be 98% precise by the end of 2021.
And, of course, there will be a lot of financial investment chances in this space, too. Shifting topics It's going to be a great year for bitcoin. I'm bullish on it in 2021 (tech stock). That stated, I still think bitcoin will continue to be volatile. We're close to all-time highs. I would not be shocked if it drew back possibly significantly prior to going greater - tech predictions. I have actually been covering bitcoin for a long period of time now. Among the very first research study reports I ever published was on bitcoin. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
But at the time of that initial suggestion, I entitled my report "What's the Big Deal With Bitcoin?" That reveals you where the conversation was at the time. We were mostly educating readers. However that's not the big concern anymore. Now we're seeing institutional cash lastly take an interest in bitcoin. Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, specific niche business. Mass, Mutual is a trusted 170-year-old institution. So think of that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. artificial intelligence. Regards, Jeff Brown, Editor, The Bleeding Edge I have a bonus offer forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than twenty years. These business raised an overall of $172 billion. That's an all-time high beating the previous annual record by 43%. I anticipate 2021 will be another record year in IPOs. There are so many terrific private business on the verge of striking the public markets And I've been working on a brand-new method for you to invest even before these companies go public.
This chance has been constructing over the last few years. I can't wait to inform you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to find out all the details. Go right here to schedule your spot totally free.
Emma Walsh here, managing editor of the Journal. Regular Journal readers know that tech isn't our normal beat (last year). And when it pertains to tech investing, we leave it to the experts. The good news is, we have a number of such professionals in our Rolodex. Our associate Jeff Brown will recognize to our longtime readers. He is one of the most accomplished tech investing experts we know (first lady). In reality, he had numerous triple-digit returns in his Brownstone Research portfolios last year. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take an appearance at the big image and anticipate what's simply around the corner.
That consists of things like 5G networks, biotech, expert system, and a lot more. These trends are experiencing exponential development and developing extraordinary opportunities for investors. I want to make certain all our readers are gotten ready for what's next. And with that in mind, let me draw the picture of what I see being available in the next 12 months Our new 5G (fifth-generation) wireless networks are a subject I have actually been covering for years now. jeff brown market predictions. However despite what numerous readers might believe, this is a trend that's just beginning. Even though the COVID-19 pandemic disrupted supply chains last year, an excellent 250 million 5G-enabled devices were still offered.
And all of this ultimately led to Apple postponing the release of the 5G-enabled i, Phone 12 by two months (black sea). Losing 2 months of manufacturing and sales truly impacts the number of 5G gadgets are sold in the fiscal year. When you consider all of that, offering 250 million systems is impressive. More significantly, the hold-ups triggered by the pandemic developed a heap of pent-up demand. And that demand is now going to be pushed into 2021. In truth, I anticipate that more than 500 million 5G gadgets will be delivered in 2021 - jeff brown 1 biotech company. And that's not my only 5G prediction When I've spoken about 5G in the past, I've described its 3 different stages.
In Phase Two, 5G devices go on sale. 5G phones and other items start to reach consumers. And in Phase Three, 5G services begin to be used (jeff brown stock market prediction). That's when we begin to see applications working on 5G networks. Consider things like huge multiplayer video games over a cellphone. That's not possible with 4G. It will be with 5G. And my 2nd 5G prediction for 2021 is that we will begin Phase Three by this summer. This begins something of a virtuous cycle: Many people do not actually care about the technology. But they will care if there are exciting applications that can only be accessed with a 5G phone.
That results in more 5G apps being established. In truth, 5G is going to open a suite of extraordinary applications: self-driving vehicles, the Web of Things, robotic surgery, and more. All of these technologies need 5G. The financial investment chances moving forward will be massive. Stepping away from 5G, the next essential innovation I predict in 2021 is CRISPR hereditary editing. CRISPR means "clustered frequently interspaced brief palindromic repeat." It's a mouthful. However it's one of the most interesting developments in biotechnology. At a high level, CRISPR is a technology that can modify our genetic makeup as if it were software.
The program can crash or not operate properly. CRISPR uses a similar idea however with our hereditary code. "Typos" in our genome can result in illness. CRISPR can remedy these "typos." For many years, CRISPR was mostly a niche innovation that wasn't well comprehended. And throughout that time, there were really just 3 business operating in this area. But things are altering. CRISPR is no longer simply theoretical. We're seeing actual outcomes. We're treating diseases and seeing that this technology simply works. And as a result, a "second crop" of early-stage CRISPR business is going public and delivering extraordinary returns. This entire industry is efficiently a greenfield opportunity.
There's room for lots of companies to exist in this area. the legacy report prediction. And there will be more. That's my forecast for CRISPR in 2021. I predict that 2 or 3 more genetic editing companies will hold their IPOs. Sticking to biotechnology, we are seeing fantastic things taking place at the merging of biotech and expert system (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its most current Alpha, Fold software application can accurately predict the folding of a protein based entirely on its amino acid series with 92. 4% precision. That is very important due to the fact that the method a protein in the human body folds figures out if a pharmaceutical will have the ability to bind to that protein and work.
Historically, this has been a trial-and-error process. And now, Alpha, Fold can forecast protein folding with 92. 4% accuracy. That's going to make it much easier to produce drugs that do what they're developed to do. And here's my next prediction. I anticipate that Alpha, Fold will be 98% precise by the end of 2021. And we will see not just one however numerous drug treatments produced using this innovation. This was among those advancements that practically nobody noticed. But it's going to have profound implications for curing disease. And, obviously, there will be lots of financial investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be unpredictable. We're close to all-time highs. I wouldn't be shocked if it pulled back maybe significantly prior to going greater. I've been covering bitcoin for a very long time now. Among the very first research reports I ever published was on bitcoin - tech stocks. That remained in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for any person who followed my recommendation. However at the time of that preliminary recommendation, I entitled my report, "What's the Big Offer With Bitcoin?" That reveals you where the discussion was at the time.
But no one is asking that concern anymore. Now, we're seeing institutional money lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. brownstone research. Mass, Mutual is a 150-year-old organization. So think of that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. Which's a big factor why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have one more bonus forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown deserves about $27. 5 million and claims the information depends on date as of February 2021, but we could not individually verify this claim. Offered Jeff Brown's past, he likely has a substantial net worth, however we can't hammer down a precise figure at this minute. Brown is best known for his sage-like capability to select winning innovation stocks. He spent more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience offers him an exceptional perspective on the marketplace. He's always on the hunt for brand-new chances, and he shares many of his finest choices in the Future Report.
That's full marks, however it's not ridiculously reasoned. Brown has an outstanding credibility as a stock-picker, and he successfully predicted some of the biggest economic events of the previous twenty years. Although he does not appear to release his choices to the general public, the service's success is a direct sign of Brown's stock-picking expertise. Nobody on Wall Street gets it ideal each time, however Jeff Brown's accurate predictions have actually earned him legions of devoted fans. That states a lot about his capability. The Future Report is published by Brownstone Research, a prominent financial research publisher. Brownstone Research provides numerous research services with a wide range of expertises - angel investor.
The company is also connected with Bonner & Partners, another well-respected research publisher - jeff brown genome sequencing stock. On its site, Brownstone says its objective is to provide retail financiers with professional-grade research study: "For too long, the very best investment research has actually not been offered to private financiers. It has actually been usually scheduled for financial investment banks, hedge funds, personal equity, and high-net-worth clients. jeff brown 2021 predictions. The mission of Brownstone Research is to make that type of proprietary research study available to any investors wanting to acquire an edge in the markets. The objective is simple to deliver unique and lucrative investment research study found no place else." -Brownstone Research website excerpt from the Jeff Brown is the creator of Brownstone Research study, and he also works as the company's Chief Investment Analyst.
With Brown assisting the ship, Brownstone Research is a powerhouse publisher with lots to use its customers. After years of steady success at the helm of top-tier business like Tesla and Space, X, Elon Musk is a home name throughout the majority of America. If you understand even a little bit about the market, you know that he has a credibility as a King Midas of sorts. last week. Whatever he touches relies on gold! Jeff is well aware of Elon Musk's executive prowess, so he always has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next big task.
In truth, Brown believes S.A.V. jeff brown biotech stock pick for 2020. might be "the most significant pattern of the 2020s, and he's not alone. Take a look at these quotes from other popular S.A.V. bulls: Elon's next huge act will be weding 2 advanced technologies: synthetic intelligence and electric automobiles. Musk hopes the mix will help him establish the very first fully-autonomous, self-driving automobiles ever. It's nothing except the automobile industry's Holy Grail. As you know, electric vehicles and self-driving car stocks have actually been huge this year, but the Wall Street machine has been huge on buzz without much concrete result. Despite a drastic increase in competition over the previous few years, Brown still believes Musk has the best chance of putting it all together.
tech might be the magic string that connects everything together. S.A.V. stands for Shared Autonomous Lorry, and it could be the future of transportation. Essentially, this technology would allow you to rent your cars and truck as a self-governing, self-driving taxi when you're not utilizing it. You simply leave the vehicle and press a button on an app that tells the vehicle to "join the fleet." Next thing you understand, you're unwinding on your couch while your car shuttles ride-sharers around town. Most importantly, you get to keep a hefty chunk of the profits. It sounds insane, however it could be closed than you think.